AMNIOTIC MEMBRANE TRANSPLANTATION IN THE OCULAR SURGERY
Abstract
Background. To review the use and proposed mechanisms of amniotic membrane transplantation in the ocular surgery: preparing and storage; indication for the use of amniotic membrane and description of different surgical procedures.
Methods. Significant clinical and experimental publications are reviewed and our results are presented.
Results. Amniotic membrane transplantation stimulates epithelialization and has anti-inflammatory and anticicatrical effect.
Conclusions. Good results of treatment with amniotic membrane transplantation can be seen in resolving a persistent epithelial defect of the cornea, symptomatic bullous keratopathy after cataract surgery, acute chemical and thermal burn of the ocular surface and limbal stem cell deficiency.
Downloads
References
De Rotth A. Plastic repair of conjunctival defects with fetal membranes. Arch Ophthalmol 1940; 23: 522–5.
Sorsby A, Symons HM. Amniotic membrane grafts in caustic burns of the eye (burns of the second degree). Br J Ophthalmol 1964; 30: 337–45.
Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995; 14: 473–84.
Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997; 123: 303–12.
Chen HJ, Piers RTF, Tseng SCG. Amniotic membrane transplantation for severe neurotrophic ulcers. Br J Ophthalmol 2000; 84: 826–33.
Kruse FE, Rohrschneider K, Volcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 1999; 106: 1504–11.
Pires RTF, Tseng SCG, Prabhasawat P, Barton K et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol 1999; 117: 1291–7
Mejia L, Santamaria JP, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea 2002; 21: 342–5.
Prabhasawat P, Barton K, Burkett G et al. Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision. Ophthalmology 1997; 104: 974–85.
Ma DHK, See LC, Liau SB et al. Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatement. Br J Ophthalmol 2000; 84: 973–8.
Schimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft in patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 1998; 82: 235–40.
Tsubota K, Satake Y, Ohyama M et al. Surgical reconstruction of the ocular surface in advanced ocular cicatrical pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 1996; 122: 38–52.
Shimazaki J, Yang HY, Tsubota K. Amniotic mebrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 1997; 104: 2068–76.
Tseng SCG, Prabhasawat P, Barton K et al. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 1998; 116: 431–41.
Koizumi N, Inatomi T, Quantock AJ et al. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 2000; 19: 65–71.
Schwab I. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 2000; 19: 421–6.
Panda A. Amniotic membrane in ophthalmology (fresh v preserved tissue). Br J Ophthalmol 1999; 83: 748–52.
Van Herendael BJ, Oberti C, Brosens I. Microanatomy of the human amniotic membranes. A light microscopic, transmission, and scanning electron microscopic study. Am J Obstet Gynecol 1978; 131: 872–80.
Fukuda K, Chikama T, Nakamura M, Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea and conjunctiva. Cornea 1999; 18: 73–9.
Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol 1999; 83: 748–52.
Sippel KC, Ma JJK, Foster CS. Amniotic membrane surgery. Curr Opin Ophthalmol 2001; 12: 269–81.
Letko E, Stechschulte SU, Kenyon KR et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol 2001; 119: 659–63.
Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999; 83: 399–402.
Terranova VP, Lyall RM. Chemotaxis of human gingival epithelial cells to laminin. A mechanism for epithelial cell apical migration. J Periodontol 1986; 57: 311–7.
Khodadoust AA, Silverstein AM, Kenyon DR et al. Adhesion of regenerating corneal epithelium. The role of basement membrane. Am J Ophthalmol 1968; 65: 339–48.
Meller D, Tseng SC. Conjunctival epithelial cell diferentiation on amniotic membrane. Invest Ophthalmol Vis Sci 1999; 40: 878–86.
Boudreau N, Sympson CJ, Werb Z et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891–3.
Kim JS, Kim JC, Na BK et al. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res 2000; 70: 329–37.
Park WC, Tseng SC. Modulation of acute inflamation and keratocyte death by suturing, blood and amniotic membrane in PRK. Invest Ophthalmol Vis Sci 2000; 41: 2906–14.
Woo HM, Kim MS, Kweon OK et al. Effect of amniotic membrane on epithelial wound healing and stromal remodelling after excimer laser keratectomy in rabbit cornea. Br J Ophthalmol 2001; 85: 345–9.
Ueta M, Sano Y, Sotozono C. Immunosuppressive properties of human amniotic membrane. Invest Ophthalmol Vis Sci 2001; 42: S473–S473.
Solomon A, Rosenblatt M, Monroy D et al. Suppression of interleukin 1 alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol 2001; 85: 444–9.
Heiligenhaus A, Bauer D, Wasmuth S et al. Influence of amniotic membrane transplantation on neutrophils in the HSV infected cornea. Invest Ophthalmol Vis Sci 2001; 42: S45–S45.
Choi TH, Tseng SC. In vivo and in vitro demonstration of epithelial cellinduced myofibroblast differentiation of keratocytes and an inhibitory effect by amniotic membrane. Cornea 2001; 20: 197–204.
Na BK, Hwang JH, Kim JC. Analysis of human amniotic membrane components as proteinase inhibitors for development of therapeutic agent of recalcitrant keratitis. Trophoblast Res 1999; 13: 459–66.
Messmer EM. Hypopyon after amniotic membrane transplantation. Ophthalmology 2001; 108: 1714–5.
Gabler B, Lohmann CP. Hypopyon after repeated transplantation of human amniotic membrane onto the ocular surface. Ophthalmology 2000; 107: 1344–6.
Akle CA, Adinolfi M, Welsh KI et al. Imunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 1981; 2: 1003–5.
Solomon A, Pires RTF, Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 2001; 108: 449–60.
Anderson SB, Ferreira de Souza R, Hofmann-Rummelt C, Seitz B. Corneal calcification after amniotic membrane transplantation. Br J Ophthalmol 2003; 87: 587–91.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
